People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CoapTech, Inc. | — | Other Health Care | Series A | $18.9M | $32.2M | 2024 |
| Dabs Advanced Biotech Solutions LLC | — | Biotechnology | Series A | $5.0M | $10.0M | — |
Tim Collins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tim Collins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Osborne | 1 | 5 |
| William Niland | 1 | 4 |
| Jeffrey Katz | 1 | 3 |
| William Walker | 1 | 2 |
| Timothy Collins | 1 | 2 |
| Peter Boyd | 1 | 2 |
| Howard Carolan | 1 | 1 |
| Steven Tropello | 1 | 1 |
| Daniel Teo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.